-
EP4149949
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4149949
| EP4149949 - BORONIC ACID DERIVATIVES AND SYNTHESIS, POLYMORPHIC FORMS, AND THERAPEUTIC USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 17.02.2023 Database last updated on 08.10.2024 | |
| Former | The international publication has been made Status updated on 12.11.2021 | Most recent event Tooltip | 16.04.2024 | Supplementary search report | published on 15.05.2024 [2024/20] | Applicant(s) | For all designated states QPEX BIOPHARMA, INC. 6275 Nancy Ridge Drive, Suite 100 San Diego, CA 92121 / US | [2023/12] | Inventor(s) | 01 /
HECKER, Scott J. San Diego, California 92121 / US | 02 /
BOYER, Serge Henri San Diego, California 92121 / US | 03 /
BIO, Matthew M. Waltham, Massachusetts 02451 / US | 04 /
FANG, Yuanqing Waltham, Massachusetts 02451 / US | 05 /
GONZALES DE CASTRO, Angela 6167 RD Geleen / NL | 06 /
LEFORT, Laurent 6167 RD Geleen / NL | 07 /
ZHU, Zuolin San Diego, California 92121 / US | 08 /
LINDER, Thomas 4040 Linz / AT | [2023/12] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2023/12] | Application number, filing date | 21800914.0 | 04.05.2021 | [2023/12] | WO2021US30690 | Priority number, date | US202063020494P | 05.05.2020 Original published format: US 202063020494 P | [2023/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021226114 | Date: | 11.11.2021 | Language: | EN | [2021/45] | Type: | A1 Application with search report | No.: | EP4149949 | Date: | 22.03.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.11.2021 takes the place of the publication of the European patent application. | [2023/12] | Search report(s) | International search report - published on: | AU | 11.11.2021 | (Supplementary) European search report - dispatched on: | EP | 15.04.2024 | Classification | IPC: | C07F5/02, C07F5/04 | [2023/12] | CPC: |
C07F5/025 (EP,IL,KR);
C07F5/04 (EP,AU);
A61K31/69 (KR);
A61P31/04 (KR);
B01J23/44 (KR);
B01J23/755 (KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/12] | Title | German: | BORSÄUREDERIVATE UND SYNTHESE, POLYMORPHE FORMEN UND THERAPEUTISCHE VERWENDUNGEN DAVON | [2023/12] | English: | BORONIC ACID DERIVATIVES AND SYNTHESIS, POLYMORPHIC FORMS, AND THERAPEUTIC USES THEREOF | [2023/12] | French: | DÉRIVÉS D'ACIDE BORONIQUE ET SYNTHÈSE, FORMES POLYMORPHES ET UTILISATIONS THÉRAPEUTIQUES ASSOCIÉES | [2023/12] | Entry into regional phase | 01.12.2022 | National basic fee paid | 01.12.2022 | Search fee paid | 01.12.2022 | Designation fee(s) paid | 01.12.2022 | Examination fee paid | Examination procedure | 25.02.2022 | Request for preliminary examination filed International Preliminary Examining Authority: AU | 01.12.2022 | Examination requested [2023/12] | 28.06.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 01.12.2022 | Renewal fee patent year 03 | 13.03.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2018005662 (REMPEX PHARMACEUTICALS INC [US]) [A] 1-105 * compound 13', example 13, paragraph [0251], pg. 93 *; | [X]WO2019075084 (QPEX BIOPHARMA INC [US]) [X] 1-45, 47-60, 62-99 * scheme 4, pg. 43-44; example 4, paragraphs [0169]-[0172], pg. 44; scheme 7, paragraph [0259] pg. 71 - paragraph [0262] pg. 72; paragraph [0285], pg. 80 *; | [A] - HECKER, S. J. et al., "Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad- Spectrum Inhibitor of Serine and Metallo-beta-lactamases", J. Med. Chem., (20200000), vol. 63, doi:10.1021/acs.jmedchem.9b01976, pages 7491 - 7507, XP055858664 [A] 1-105 * "Disodium Salt of (2S,4R)-9-Fluoro-5-hydroxy-5-oxonio-6-oxa-5-boranuidatricyclo[5.4.0.02.4]undeca-1(7),8,10-triene-8-carboxylate (35)", pg. 7503; compound 32, S79-S80, Supporting Information * DOI: http://dx.doi.org/10.1021/acs.jmedchem.9b01976 |